Drug Shortage Report for DILANTIN-125 SUSPENSION
| Report ID | 246922 |
| Drug Identification Number | 00023450 |
| Brand name | DILANTIN-125 SUSPENSION |
| Common or Proper name | PHENYTOIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN |
| Strength(s) | 125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 250ML |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-06-03 |
| Estimated end date | Unknown |
| Actual end date | 2025-03-10 |
| Shortage status | Resolved |
| Updated date | 2025-03-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-03-11 | English | Compare |
| v6 | 2025-03-10 | French | Compare |
| v5 | 2025-03-10 | English | Compare |
| v4 | 2025-01-21 | French | Compare |
| v3 | 2025-01-21 | English | Compare |
| v2 | 2025-01-07 | French | Compare |
| v1 | 2025-01-07 | English | Compare |
Showing 1 to 7 of 7